Denali Therapeutics DNLI
NASDAQ DNLI
$19.83 -0.02 (-0.08%)
As of: Nov 11, 2026 · 3:35 PM EST

Denali Therapeutics (DNLI) Change in Accrued Expenses (2017 - 2026)

Updated

Denali Therapeutics' Change in Accrued Expenses was $6.52 million in Q3 2026, up 244.9% from $1.89 million a year earlier and up 98.2% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Change in Accrued Expenses (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Denali Therapeutics' Change in Accrued Expenses was $136,000 through Sep 30, 2026; for FY2025, it was $465,000, down 85.7% from FY2024.

  • Change in Accrued Expenses shows a five-year compound annual growth rate of -53.8% (FY2020 to FY2025).
  • In earlier years, Change in Accrued Expenses was $3.25 million in FY2024 (+22.7%), $2.65 million in FY2023 (-75.7%), $10.92 million in FY2022 (+130.7%) and $4.73 million in FY2021 (-78.6%).
  • Quarterly Change in Accrued Expenses has moved between -$32.21 million (Q2 2023) and $24.59 million (Q3 2024) over five years.
  • The best year-over-year quarter for Change in Accrued Expenses over five years was Q2 2022 (growth of 359.3%); the worst was Q3 2025 (a decline of 92.3%).
  • Per Business Quant data, DNLI's Change in Accrued Expenses in the three quarters before Q3 2026 was $3.29 million (Q2 2026), -$22.4 million (Q1 2026) and $12.73 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn 6.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 6.52 Mn
Jun 30, 2026 3.29 Mn
Mar 31, 2026 -22.40 Mn
Dec 31, 2025 12.73 Mn
Sep 30, 2025 1.89 Mn
Jun 30, 2025 -4.47 Mn
Mar 31, 2025 -9.69 Mn
Dec 31, 2024 -2.84 Mn
Sep 30, 2024 24.59 Mn
Jun 30, 2024 -20.82 Mn
Mar 31, 2024 2.32 Mn
Dec 31, 2023 14.31 Mn
Sep 30, 2023 734,000.00
Jun 30, 2023 -32.21 Mn
Mar 31, 2023 19.81 Mn
Dec 31, 2022 4.03 Mn
Sep 30, 2022 9.33 Mn
Jun 30, 2022 5.87 Mn
Mar 31, 2022 -8.31 Mn
Dec 31, 2021 7.77 Mn
API Access

Denali Therapeutics Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=DNLI&period=max&api_key=YOUR_API_KEY